Decreased levels of adiponectin are associated with deregulated cerebral insulin signaling and AD pathogenesis in aged individuals or those with T2D mellitus (T2DM), particularly among those with decreased CNS adiponectin levels [197,198]. This evidence concerns the gene ADIPOQ and Alzheimer disease.